Your session is about to expire
← Back to Search
Injectable DMAU for Male Birth Control (DMAU Trial)
DMAU Trial Summary
This trial will study the safety and tolerability of a new drug, Dimethandrolone Undecanoate (DMAU), given as an injection.
DMAU Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowDMAU Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.DMAU Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- You need to have a body mass index (BMI) of 33 or lower. This is calculated by dividing your weight in kilograms by your height in meters squared.I am between 18 and 50 years old.I weigh 60 kg or more.My recent tests show significant abnormal results.I have a serious condition like diabetes or obesity.My blood tests show liver or kidney problems.I have had breast cancer before.I have a history of heart, kidney, liver, prostate issues, or significant mental health problems.I am a healthy male as confirmed by recent medical exams and tests.I weigh 60 kg or more.I haven't used androgens in the last 3 months, except for long-acting testosterone injections.I am currently using body building substances or nutritional supplements.I have liver tumors or active liver disease.I have a known androgen deficiency due to a brain or testicular condition.I haven't used hormonal therapy in the last three months.I have a history of testicular disease or hormonal control issues.I have high blood pressure, even if it's controlled with medication.I am not taking sex steroids or drugs that affect steroid metabolism.I have sleep apnea that has not been treated.I haven't used hormonal therapy in the last three months.I am between 18 and 50 years old.I will not donate blood or plasma while in the study.I want to try for a baby within the first 7 months of the study.I am not taking medications that interact with DMAU.I am a healthy male as confirmed by recent medical exams and tests.
- Group 1: Placebo
- Group 2: Dimethandrolone Undecanoate
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What kind of health risks does Dimethandrolone Undecanoate pose to individuals?
"There is sparse data on the safety and efficacy of Dimethandrolone Undecanoate, so it was rated a 1."
Is this experiment still recruiting participants?
"Indeed, the clinicaltrial.gov records demonstrate that this research endeavour is currently recruiting participants. This trial was first made public on December 1st 2016 and last modified on July 7th 2021; 84 participants are needed at 2 sites."
Does this medical trial accept individuals aged 85 or younger?
"According to the trial's requirements, only individuals aged between 18 and 50 are eligible for participation."
Has there been any other research conducted regarding Dimethandrolone Undecanoate?
"Dimethandrolone Undecanoate was first researched at University of Washington Medical Center & Health Sciences in 2016, and has since seen 18330 completed trials. Currently, 1 clinical trial remains active; a significant proportion are based out of Torrance, CA."
To what extent has participation been noted in this medical trial?
"Affirmative. Clinicaltrials.gov shows that this medical trial, which began recruiting on December 1st 2016, is currently accepting participants. 84 individuals are needed to take part in the study across 2 clinical sites."
Could I potentially qualify for this experiment?
"This clinical trial seeks 84 individuals between 18 and 50 years of age to evaluate the efficacy of male contraception. It is essential that applicants meet the following criteria: abstain from too much alcohol consumption (no more than 15 drinks a week, no drinking 24hrs before study visit), be in good physical health with BMI ≤ 33, weigh ≥60 kg., have not used hormonal therapy within last three months prior to screening, agree to use an effective birth control method when engaging in sexual activity during the course of this experiment until recovery has been confirmed and exit occurs., refrain from donating blood or plasma for duration of study period., free from any drug"
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Typically responds via
Share this study with friends
Copy Link
Messenger